A large-scale study analyzing data from over 60 million patients finds no evidence that GLP-1 receptor agonists increase suicidality risk in type 2 diabetes patients, challenging previous safety concerns
We have all heard the statistics about our health care crisis, but what drives me to work so hard is the need to transition current health care delivery systems to one that addresses the root causes of these diseases
Its important to recognize that abruptly stopping GLP-1 therapy can lead to common challenges, including weight regain and anxiety about ending treatment
Haskins, J., Gu, L., Wittchen, E
Dont treat the snp, but rather the person is the biggest mistake I see with doctors
Morning injection also places the peak side effect window during waking hours when you can eat and move intentionally, rather than during sleep when nausea can disrupt sleep architecture